These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20811626)

  • 21. Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy.
    Holgersson G; Bergström S; Liv P; Nilsson J; Edlund P; Blomberg C; Nyman J; Friesland S; Ekman S; Asklund T; Henriksson R; Bergqvist M
    Anticancer Res; 2015 Oct; 35(10):5491-7. PubMed ID: 26408714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
    Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
    Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
    Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
    J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients.
    Liu B; Tang Y; Yi M; Liu Q; Xiong H; Hu G; Yuan X
    Cancer Med; 2017 Mar; 6(3):681-688. PubMed ID: 28211612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
    Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.
    Guerra JL; Gomez D; Wei Q; Liu Z; Wang LE; Yuan X; Zhuang Y; Komaki R; Liao Z
    Radiother Oncol; 2012 Dec; 105(3):299-304. PubMed ID: 23022171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
    Antonadou D; Throuvalas N; Petridis A; Bolanos N; Sagriotis A; Synodinou M
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):402-8. PubMed ID: 12957251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study.
    Willner J; Schmidt M; Kirschner J; Lang S; Borgmeier A; Huber RM; Flentje M
    Lung Cancer; 2001 May; 32(2):163-71. PubMed ID: 11325487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer.
    Delgado BD; Enguix-Riego MV; Fernández de Bobadilla JC; Herrero Rivera D; Nieto-Guerrero Gómez JM; Praena-Fernández JM; Rivin Del Campo E; Ortiz Gordillo MJ; Fernandez Fernandez MDC; Lopez Guerra JL
    Radiother Oncol; 2019 Jun; 135():161-169. PubMed ID: 31015163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
    Pang Q; Wei Q; Xu T; Yuan X; Lopez Guerra JL; Levy LB; Liu Z; Gomez DR; Zhuang Y; Wang LE; Mohan R; Komaki R; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1332-9. PubMed ID: 23374503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of LIG4 and HSPB1 genetic polymorphisms with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.
    Xu F; Han JC; Zhang YJ; Zhang YJ; Liu XC; Qi GB; Liu D; Chen YZ; Zhao YX; Bai L
    Biomed Res Int; 2015; 2015():860373. PubMed ID: 25811031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
    Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
    Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer.
    Zhao L; Pu X; Ye Y; Lu C; Chang JY; Wu X
    Cancers (Basel); 2016 Feb; 8(2):. PubMed ID: 26901225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancer.
    Jaksic N; Chajon E; Bellec J; Corre R; Ricordel C; de Latour B; Lena H; Schick U; de Crevoisier R; Castelli J
    Radiat Oncol; 2018 Aug; 13(1):147. PubMed ID: 30103774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
    Yi M; Tang Y; Liu B; Li Q; Zhou X; Yu S; Fu S; Cai Y; Yuan X
    Tumour Biol; 2016 Mar; 37(3):3469-77. PubMed ID: 26449830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study.
    Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 1):6. PubMed ID: 24852396
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
    Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.